Quality and Outcome Measurements of Urological Patients

Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Urologic Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Male Urogenital Diseases Urogenital Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Urology, Hospital Center Biel, Biel, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients treated at the study sites, signed informed consent

Exclusion criteria

No consent to record medical history

Treatment and study plan

Standard of care

Other

Patients are treated according to the standard of care for each individual disease.

Primary outcomes

Disease specific primary endpoint

Time frame: 4-5 years

Neuronal networks will be trained to define the respective endpoints for the diseases

Study contacts

Contact information is provided by the study sponsor or research team.

Roland Seiler, Prof.

CONTACT

[email protected]

+41316321349

Sponsors and collaborators

Lead sponsor

Insel Gruppe AG, University Hospital Bern

Other

Collaborators

Hospital Centre Biel/Bienne

Registry information

Important dates

Study start: 2021
Primary completion: 2026
Study completion: 2028
First posted: Feb 21, 2021
Registry last updated: Mar 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting